Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.99
Delayed Data
As of Feb 27
 -0.19 / -2.07%
Today’s Change
7.09
Today|||52-Week Range
11.47
+8.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues106.0K803.0K1.5M12.0M
 
 
 
 
 
Cost of Goods Sold34.0M29.7M--362.0K
 
 
 
 
Depreciation And Amortization1.2M879.0K871.0K742.0K
 
 
 
 
 
 
Operating ExpensesGross Income-35.0M-29.8M--10.9M
 
 
 
 
General Expenses5.1M7.9M42.8M72.8M
 
 
 
 
 
Research And Development----23.5M17.2M
 
 
 
Total Operating Expenses40.2M38.6M43.6M73.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.1M-37.8M-42.2M-61.9M
 
 
 
 
 
Extraordinary Charge0.000.000.00-22.9M
 
 
Interest Expense On Debt0.001.9M3.6M7.8M
 
 
 
 
Other Expenses542.0K117.0K-660.0K101.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.5M-39.5M-46.3M-92.3M
 
 
 
 
 
Income Taxes-399.0K-16.2M0.000.00
 
 
 
Preferred Dividend-3.4M-3.4M-1.1M0.00
 
 
 
 
Discontinued Operations612.0K2.2M0.000.00
 
 
 
Extraordinary Items0.0074.9M0.000.00
 
 
Net Income-38.5M-21.0M-46.3M-92.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.9M23.9M17.4M31.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.9M23.9M17.4M31.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$26.38$31.39-$2.72-$2.90
 
 
 
 
 
EPS Diluted-$1.75-$1.02-$2.72-$2.90
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account